Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Int. j. cardiovasc. sci. (Impr.) ; 33(5): 447-456, Sept.-Oct. 2020. tab, graf
Article in English | LILACS | ID: biblio-1134404

ABSTRACT

Abstract Background Fatty acids are important components of diet that may influence the development of CVD. Objective To verify the relationship of dietary fatty acids with cardiometabolic markers in individuals at the cardiometabolic risk. Methods This cross-sectional study involved 282 subjects (116 M/166 F, 42 ± 16 years) attended the Cardiovascular Health Care Program, Universidade Federal de Viçosa (Brazil). Anthropometric and body composition measurements as well as metabolic and inflammatory markers were assessed by standard procedures. Demographic and lifestyle variables were obtained by semi-structured questionnaire. Food consumption was evaluated by 24h recall. Student's t-test or Mann-Whitney-U test and chi-square test were used, considering the statistical significance level of 5% probability. Results Individuals who eaten fat, fatty acids saturated and fatty acids polyunsaturated above recommendation (> 35, 7%, and 10% of caloric intake) were more likely to be overweight (p < 0.05). Those individuals with higher intake of medium-chain fatty saturated acids (≥ 1.05 g/d) had lower values (p < 0.05) of body mass index, waist circumference, waist-hip ratio and waist-height ratio and higher values (p < 0.05) of total leukocytes, C-reactive protein and total cholesterol, and LDL. Subjects with higher of palmitoleic acid intake (≥ 0.94 g/d) presented higher values of BMI, fat percentage and HOMA-IR (p < 0.05). Conclusion This cross-sectional study found different associations of dietary fat and cardiometabolic risk related to adiposity and inflammatory markers, according with chain-size and saturation, indicating the need the more detailed on the dietary assessment of obese patients to identify risk factors and established best strategies to control. (Int J Cardiovasc Sci. 2020; [online].ahead print, PP.0-0)


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Fatty Acids/adverse effects , Cardiometabolic Risk Factors , Obesity/prevention & control , Dietary Fats , Biomarkers , Cross-Sectional Studies , Metabolic Syndrome/diet therapy , Metabolic Syndrome/prevention & control , Overweight , Adiposity , Obesity/complications
SELECTION OF CITATIONS
SEARCH DETAIL